Nureflex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nureflex

What is Nureflex?

Nureflex is a medicinal product used to manage pain and reduce fever. It belongs to a group of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). These medications work by inhibiting the production of prostaglandins, which are naturally occurring chemicals in the body that signal pain and trigger inflammatory responses.

Primary Uses

The medication is most commonly utilized for the short-term treatment of acute conditions. Its applications typically include:

  • Pain Relief: Alleviating mild to moderate pain such as headaches, dental pain, and muscular aches.
  • Fever Reduction: Lowering elevated body temperature associated with common colds, flu, or other febrile illnesses.

Formulations and Action

Nureflex is frequently available in liquid or syrup forms specifically designed for pediatric use, though it may also be found in other oral formats. The active substance, ibuprofen, is absorbed into the bloodstream after ingestion. Once active, it helps to decrease swelling and sensitivity at the site of discomfort while acting on the body's internal thermostat to mitigate fever.

What side effects are possible with Nureflex?

Possible Side Effects and Safety Information

Nureflex, which contains the active substance ibuprofen, is a non-steroidal anti-inflammatory drug (NSAID). Its safety profile is characterized by class-wide risks, primarily involving the Gastrointestinal (GI) and Cardiovascular systems. The lowest effective dose should be used for the shortest possible duration to minimize adverse effects.

Serious and Clinically Significant Risks

Regulatory warnings highlight the potential for serious GI adverse events such as bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning and may be fatal. The risk is generally increased with higher doses, longer duration of use, and in the elderly population.

There is also a documented risk of serious arterial thrombotic events, including myocardial infarction (heart attack) and stroke. This risk may be increased with high daily doses (e.g., 2400 mg or higher) and prolonged use. Other serious reactions include severe cutaneous adverse reactions (SCARs), acute renal failure, and severe hypersensitivity/anaphylactic reactions.

Common and Other Adverse Reactions

Commonly reported side effects often involve the GI tract (e.g., dyspepsia, nausea, abdominal pain) and the nervous system (e.g., headache, dizziness). Less common reactions include various skin rashes, fluid retention (oedema), and hypertension. Prolonged use for headache relief may potentially lead to medication-overuse headache.

Population-Specific Restrictions

The product is contraindicated in patients with active or a history of recurrent peptic ulcer/haemorrhage, severe heart failure, or severe renal or hepatic failure. Use after 20 weeks of pregnancy is not recommended due to the potential for fetal renal dysfunction and subsequent complications. Patients with established cardiovascular disease or risk factors (e.g., hypertension, diabetes) should be carefully assessed before initiation of long-term, high-dose therapy.

Overdose and Emergency Response

The regulatory information for Nureflex (Ibuprofen) overdose mandates that any suspected over-ingestion requires immediate medical attention. Contacting a poison control center or emergency services is the required first step. Management, as defined by regulatory sources, is primarily symptomatic and supportive of vital functions.

Documented Overdose Manifestations

Officially documented clinical signs and symptoms often include:

  • Gastrointestinal Effects: Nausea, vomiting, and epigastric pain.
  • CNS Effects: Dizziness, drowsiness, lethargy, tinnitus, headache, and nystagmus (involuntary eye movement).

Severe Outcomes and Required Actions

Overdose may lead to severe or life-threatening outcomes documented in regulatory labeling. Immediate medical assessment and monitoring is required for potential complications.

Severe Manifestation Status in Regulatory Documents
CNS Depression Coma, seizures, and loss of consciousness
Metabolic Severe metabolic acidosis
Organ Dysfunction Acute renal failure and hepatic dysfunction

No specific antidote is known for Ibuprofen overdose. Supportive interventions, such as gastric decontamination with activated charcoal, are officially listed options depending on the dose and time of ingestion.

Population-Specific Notes

Regulatory documents note that Central Nervous System manifestations are more commonly observed in pediatric patients following a significant overdose. The risk of acute renal failure as a severe outcome is increased in patients with pre-existing renal impairment.

Therapeutic Uses of Nureflex

What Nureflex Treats: Main Uses and Benefits

Nureflex is applied across key therapeutic domains where additional symptomatic support is needed, primarily targeting symptoms that cause noticeable interference with daily stability. The medication is used to assist with easing the overall symptom load associated with acute, recurrent, and chronic episodes.

The therapeutic scope is relevant for conditions presenting with mild to moderate pain and elevated body temperature. Nureflex is commonly used in scenarios involving symptoms such as headaches, dental pain, musculoskeletal aches, and discomfort related to sprains, strains, and chronic joint disorders like arthritis. It also offers supportive antipyretic assistance for fever and generalized aches during illnesses like the cold or flu.

“The medication is applied to ease symptom load and supports general well-being during symptomatic phases.”

This medication generally helps with relief for various forms of acute and episodic pain, and may assist with maintaining functional stability when symptoms escalate.

Quick Fact Symptom Focus
Symptomatic Relief Helps with Pain, including headache and dental pain.
Targeted Relief Stiffness and discomfort associated with inflammatory states.
Fever Support Supports the management of elevated body temperature during systemic illness.

Eligibility and Restrictions for Use

Nureflex (Ibuprofen) eligibility is defined by official regulatory criteria concerning age, physiological status, and underlying medical conditions. Use is generally approved for adults and adolescents and for children typically over 6 months old and weighing at least 5 kg, depending on the specific formulation. Older adults should proceed with caution due to the documented increased risk of adverse reactions.

Contraindicated Populations

Use is strictly contraindicated for several groups, including those with a known hypersensitivity to NSAIDs, patients with active or recurrent gastrointestinal ulceration or bleeding, and individuals with severe and uncontrolled organ failure (severe heart failure, severe renal insufficiency, or severe hepatic failure). The medicine must also not be used in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Restricted and Conditional Use

Nureflex is contraindicated during the third trimester of pregnancy (from 30 weeks gestation) and is not recommended during the first and second trimesters. While use during breastfeeding is generally considered acceptable for short-term, low-dose therapy, it should be restricted. Patients with mild-to-moderate organ impairment, uncontrolled hypertension, or a history of inflammatory bowel disease have restricted eligibility and must use the medicine with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented drug and substance interactions for Nureflex (ibuprofen), based on regulatory information.

Contraindicated Combinations

Ibuprofen must not be co-administered with other NSAIDs (including COX-2 inhibitors) or with Aspirin (Acetylsalicylic Acid, ASA) when used at analgesic or anti-inflammatory doses (typically above 75 mg daily), due to an increased risk of serious gastrointestinal events. Products containing Paracetamol are also restricted due to elevated risk of adverse effects.

Clinically Significant Interactions

Interaction Type Interacting Substances/Classes
Increased Bleeding Risk (Pharmacodynamic) Anticoagulants (e.g., Warfarin), Antiplatelet Agents, SSRIs, and Oral Corticosteroids.
Increased Drug Levels (Pharmacokinetic) Lithium and Methotrexate (due to reduced renal clearance), Cardiac Glycosides.
Reduced Efficacy ACE Inhibitors, Angiotensin II Antagonists, and Diuretics (reduced blood pressure control).

Administration Constraints

When co-administered with low-dose Aspirin for cardioprotection, official documents state that ibuprofen should be taken at least 8 hours before or at least 30 minutes after the low-dose Aspirin dose to prevent interference with its intended antiplatelet function. Consumption of Alcohol may also increase the risk of gastrointestinal and central nervous system adverse effects. Food intake may reduce the maximum concentration of ibuprofen and delay the time to peak concentration.

Mechanism of Action

The core action of Nureflex is defined by its ability to interfere with key enzymatic steps in the body's signaling pathways, thereby influencing signal transduction within pathways at both central and peripheral levels.

Inhibiting the Cyclooxygenase (COX) Enzymes

The active ingredient acts as a non-selective, reversible inhibitor of the Cyclooxygenase (COX) enzymes (specifically COX-1 and COX-2). By binding to these targets, the drug blocks the conversion of arachidonic acid into prostanoids, which are lipid-derived signaling molecules. This mechanism initiates the cascade by temporarily suppressing the catalytic function of the target enzymes.

Modulating the Prostanoid Synthesis Cascade

The inhibition directly interrupts the Prostanoid Synthesis Pathway, reducing the production of specific mediators, notably Prostaglandin E2 (PGE2). This mechanism influences signals characteristic of the eicosanoid cascade in systems requiring targeted pathway adjustment.

Dampening Nociceptor Sensitization and Central Thermogenesis

The decrease in PGE2 concentration leads to a desensitization of peripheral nociceptors, reducing the sensitization of these receptors to endogenous stimuli. Simultaneously, the reduction of PGE2 in the hypothalamus resets the body's core temperature set point, allowing the central set point for temperature control to return to the biological baseline.

Dosage and Administration Information

Nureflex (ibuprofen) is administered through several officially approved routes. The primary method is oral intake, utilizing various dosage forms including tablets, capsules, and liquid suspensions. Topical formulations, such as gels, are available for local application, and an Intravenous (IV) solution is approved for use in supervised clinical settings when oral administration is not feasible.

Dosing and Frequency

Standard adult dosing for general use ranges from 200 mg to 400 mg per dose. Doses are typically scheduled every 4 to 6 hours as needed, and the minimum interval between doses must be strictly observed. For conditions requiring prescription strength, doses may reach 800 mg per intake, with the total daily amount administered in divided doses.

Regulatory documents mandate strict maximum daily limits. The total daily intake for self-medication (OTC) is generally limited to 1200 mg. Under medical supervision for certain conditions, the official maximum daily dose may extend up to 3200 mg.

Administration Conditions

Oral forms are officially instructed to be taken with water and ideally with or after food or milk to aid gastrointestinal tolerability. The IV form requires dilution and must be administered as a slow infusion over a prescribed time. Use must always adhere to the principle of employing the lowest effective dosage for the shortest possible duration. For self-medication of pain, use is typically restricted to no more than 10 days without professional oversight.

In pediatric patients, dosing is based on body weight (mg/kg). Use in older adults and patients with hepatic or renal impairment requires caution, with administration often beginning at the lower end of the adult dosing range.

Recent Clinical Evidence

Recent Clinical Evidence Overview

This summary provides a neutral overview of research studies examining Nureflex for its authorized uses. The information is strictly based on clinical trial findings and does not constitute medical advice.


Research Focus Areas

Clinical trials have primarily focused on two main areas of use: acute pain management and effects on mobility in specific neurological conditions.

  • Acute Pain Management: Multiple randomized, placebo-controlled trials (RCTs) have assessed the agent's impact on acute pain following procedures or musculoskeletal injury. Studies reported a decrease in pain observed over the study period in the treatment group compared to placebo. One comprehensive review found that a single dose conferred at least a 50% reduction in pain relief in approximately half of patients with moderate-to-severe postoperative pain.
  • Mobility in Neurological Conditions: Research evaluated whether the administration of the agent affected the ability to walk and functional status in specific adult populations. Findings were variable; some studies reported a statistically significant change in walking speed, while others did not observe a definitive effect. Outcomes related to functional status were also explored.

Safety and Risk Profile in Studies

Safety data collected across trials indicated that the most frequently reported adverse events were gastrointestinal discomfort and headache. Safety protocols in the studies specified regular evaluation of liver function during the treatment period.

Contraindications Reported in Research
Severe kidney disease
Known hypersensitivity to the drug’s components
Active peptic ulcer disease or gastrointestinal bleeding

Key Studies & References

  1. Evaluating the clinical safety of ibuprofen arginine: a narrative review
  2. Effects of acetaminophen and ibuprofen monotherapy in febrile children: a meta-analysis of randomized controlled trials
  3. Ibuprofen Bioavailability Study (Reference to Pharmacokinetic Data and Contraindications)

Frequently Asked Questions (FAQ)

Common questions about Nureflex (FAQ)

Q: Is it true that Nureflex can cause stomach upset?

Yes, official product information notes that gastrointestinal (GI) discomfort, dyspepsia, nausea, and abdominal pain are common adverse reactions. Regulatory documents note that oral forms of Nureflex are generally administered with food or milk, which may help reduce the potential for stomach upset and aid gastrointestinal tolerability.

Q: Are there certain foods or drinks that should be avoided while taking Nureflex?

Regulatory documents state that consuming alcohol while using Nureflex may increase the risk of adverse effects on both the gastrointestinal system and the central nervous system. Beyond alcohol, oral forms are generally mentioned in official documents as being taken with or after food to aid tolerability.

Q: Does Nureflex interact with common over-the-counter pain relievers?

Official labeling contraindicates (forbids) the co-administration of Nureflex with other non-steroidal anti-inflammatory drugs (NSAIDs) and products containing paracetamol. This restriction is due to an increased risk of serious adverse events when combining these medications.

Q: Can Nureflex be taken if a person has a history of allergic reactions to medicines?

According to official product information, Nureflex is contraindicated for use in patients who have a known history of hypersensitivity or an allergic reaction, asthma attack, or other severe reaction after taking the active substance, aspirin, or any other NSAID.

Q: Why do some forums talk about taking Nureflex 'on an empty stomach'?

Regulatory documents indicate that taking the medicine after a meal may delay the time it takes for the drug to reach its peak concentration in the body. Official administration instructions emphasize taking the medicine with food or milk for better gastrointestinal tolerability, even though taking it without food may speed up the onset.

Q: Is Nureflex meant to be taken every day or just when needed?

Dosing for general use is typically described as 'as needed.' This is consistent with regulatory guidance that stresses using the lowest effective dosage for the shortest possible duration. For self-medication, use is often restricted to no more than 10 days without professional oversight.

Q: Is Nureflex the same as other medicines with similar names?

Nureflex contains the active substance ibuprofen. Many products containing ibuprofen are available under different brand names or as a generic version. While the active ingredient is the same, products may vary in their dose strength or inactive ingredients.

Q: Why is Nureflex sometimes called by a different name?

Nureflex is a brand name used by a pharmaceutical company to market the product. The active substance in the medicine is known by its official chemical name, ibuprofen. Different companies often use their own unique brand names to sell medications containing the same generic active ingredient.

Q: Is Nureflex a kind of medicine that can be addictive?

The active ingredient in Nureflex, ibuprofen, is a non-steroidal anti-inflammatory drug (NSAID). It is not classified as a controlled substance and is not generally associated with the potential for addiction or substance use disorder.

Q: Is a metallic taste in the mouth listed as a side effect of Nureflex?

A metallic taste is not explicitly listed as a common or frequent adverse reaction in official product information. However, post-marketing reports sometimes document rare, transient sensations of burning in the mouth or throat.

Q: Is it normal for Nureflex to cause a slight feeling of dizziness?

Dizziness is listed under common adverse reactions in regulatory documents. Official information lists dizziness as a common reaction. Adverse reactions are addressed through consultation with a healthcare professional.

Q: Can Nureflex be crushed or split if someone has trouble swallowing pills?

Some dosage forms of Nureflex, such as certain film-coated tablets, are officially described as being divisible into equal doses or having a break line. For patients who have trouble swallowing, liquid suspensions are also an approved form of the medicine.

Q: What are the most common reasons people stop taking Nureflex?

Official information indicates that the most frequently reported reasons for discontinuation are often related to the most common side effects. These typically involve the gastrointestinal tract, such as nausea or dyspepsia, and the nervous system, such as headache and dizziness.

Q: What is the meaning of the active ingredient in Nureflex?

The active ingredient in Nureflex is ibuprofen. This substance is chemically classified as a non-steroidal anti-inflammatory drug (NSAID). NSAIDs work by acting to reduce pain, decrease inflammation, and decrease fever.

Q: Why do some people report feeling tired after taking Nureflex?

While not always a common side effect, somnolence (drowsiness or sleepiness) or fatigue are documented as known, though less frequent, adverse reactions of the medication in official product information.

Q: Does Nureflex lose its effectiveness over time (tolerance buildup)?

The body does not typically build up a pharmacological tolerance to the active ingredient of Nureflex in a way that necessitates increasing the dose for the same effect. However, prolonged, consistent use for headache relief may potentially lead to a medication-overuse headache, which could reduce its perceived effectiveness for that condition.

Q: Are there different forms of Nureflex (e.g., tablet, liquid, injection)?

Yes, Nureflex is administered through several officially approved routes and forms. These include oral intake (tablets, capsules, and liquid suspensions), topical formulations (gels), and an intravenous (IV) solution approved for use in supervised clinical settings.

Q: What is the role of the inactive ingredients in the Nureflex tablet?

Inactive ingredients, also known as excipients, serve several important official functions. Their role is to help stabilize the active substance, assist in the manufacturing process, and provide the physical characteristics of the tablet, such as its size, color, or a break line.

Q: Is there a generic version of Nureflex available?

Yes, Nureflex contains ibuprofen, which is an active ingredient that is widely available. According to official registries, ibuprofen is available under its generic name and many other brand names, both over-the-counter and by prescription.

Q: Can Nureflex be used by people who have diabetes?

Diabetes itself is not typically listed as a direct contraindication (a reason not to use the drug). Official labeling indicates that individuals with chronic conditions such as diabetes, high blood pressure, or other cardiovascular risk factors may require assessment by a healthcare professional prior to use.

Q: What kind of research is currently being conducted on Nureflex?

While product information summarizes completed trials, information on current, ongoing research studies related to the active ingredient (ibuprofen) is typically registered in public databases. These databases, such as the NIH Clinical Trials registry, track studies for various authorized and investigational purposes.

Q: What safety precautions are mentioned for using Nureflex in warm weather?

Official regulatory documents do not specify unique safety precautions for 'warm weather' itself. However, the product information advises caution in patients who are dehydrated or hypovolemic, as these states can occur in heat and require careful monitoring of kidney function during use.

Q: Can people with liver issues use Nureflex?

Nureflex is officially contraindicated in patients with severe hepatic (liver) failure. Official documents also indicate that patients with pre-existing liver disease or mild to moderate impairment may require careful consideration and monitoring by a healthcare professional.

How should Nureflex be stored and disposed of?

The official requirements for storing and disposing of Nureflex, an Ibuprofen-based medication, are outlined in regulatory product information to maintain stability and ensure safety.

Storage Conditions

Nureflex must be stored at controlled room temperature, typically defined as below 30 C (86 F), and protected from light and moisture. Liquid suspensions must not be frozen. The product must be kept in its original container and the most critical rule is to keep it out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired medicine should preferentially use an authorized drug take-back program. If this is unavailable, the alternative is to mix the drug with an undesirable substance (such as cat litter or dirt) and seal the mixture in a container before placing it in household trash. This product should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nureflex found in:

A-Z Index: